Skip to main content
. Author manuscript; available in PMC: 2020 Apr 5.
Published in final edited form as: Int J Pharm. 2019 Jan 31;560:11–18. doi: 10.1016/j.ijpharm.2019.01.050

Table 1.

Formulation compositions and loss of phage bioactivity after spray drying.

Formulation name Phage Contents % (w/w)
Log10 titer loss after spray drying
Lactose Leucine
PEV61 90%LT 10%LC PEV61 90 10 0.3
PEV20 80%LT 20%LC PEV20 80 20 0.2
PEV61 80%LT 20%LC PEV61 80 20 0.2
PEV1 70%LT 30%LC PEV1 70 30 0.2
PEV20 70%LT 30%LC PEV20 70 30 0.5
PEV61 70%LT 30%LC PEV61 70 30 0.3
PEV20 55%LT 45%LC PEV20 55 45 0.6
PEV61 55%LT 45%LC PEV61 55 45 0.4